- 99mTc‑PSMA Left Behind: a Call for Collaboration
-
Moghadam S, Askari E, Aryana K
- KMID: 2532374
- Nucl Med Mol Imaging.
- 2022 Aug;56(4):218-219.
- doi: 10.1007/s13139-022-00753-7
-
- CITED
-
- Close
- SHARE
-
- Close
- Technetium 99m PSMA Superscan Mimicking a Bone Scan Gone Wrong
-
Osayande E, Carika F, Gerrit E
- KMID: 2532373
- Nucl Med Mol Imaging.
- 2022 Aug;56(4):211-217.
- doi: 10.1007/s13139-022-00749-3
Imaging of metastatic castrate-resistant prostate cancer to select patients suitable for peptide receptor radioligand therapy can be performed with both SPECT and PET PSMA radiotracers. Although PET radiotracers generally have... -
- CITED
-
- Close
- SHARE
-
- Close
- 68Ga‑DOTATOC Embolus Manifestation and Spontaneous Resolution by PET/CT
-
Al‑Ibraheem A, Sweedat D, Anwer F, Istatieh F, Juweid M
- KMID: 2532372
- Nucl Med Mol Imaging.
- 2022 Aug;56(4):208-210.
- doi: 10.1007/s13139-022-00752-8
68Ga-labeled somatostatin receptor analogs physiologic distribution patterns have become recognizable among nuclear medicine physicians because of the increasing routine clinical use of this modality in the work-up of neuroendocrine tumors. Some... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidentally Found Soft Tissue 99mTc‑DPD Uptake on Bone Scintigraphy Was Useful in an Early Diagnosis of Peripheral Arterial Disease
-
Bae S, Chun I
- KMID: 2532371
- Nucl Med Mol Imaging.
- 2022 Aug;56(4):202-207.
- doi: 10.1007/s13139-022-00750-w
Peripheral arterial disease (PAD) is a critical disease which is presented by occlusion of peripheral arteries, while it could result in amputation of the involved limbs if it remained untreated... -
- CITED
-
- Close
- SHARE
-
- Close
- A Prospective Pilot Study Investigating Performance of 18F‑Fluciclovine PET Imaging for Detection of Prostate Cancer 2 Years Following Primary Partial Gland Cryoablation
-
Nazemi A, Huang W, Wysock J, Taneja S, Friedman K, Gogaj R, Lepor H
- KMID: 2532370
- Nucl Med Mol Imaging.
- 2022 Aug;56(4):196-201.
- doi: 10.1007/s13139-022-00755-5
Purpose The goal of partial gland ablation (PGA) is to eradicate focal lesions of clinically significant prostate cancer (csPCa) with minimal adverse impact on functional outcomes. The primary objective of... -
- CITED
-
- Close
- SHARE
-
- Close
- Interval Changes in PSMA PET/CT During Radium‑223 Therapy for Metastatic Bone Disease from Castration‑Resistant Prostate Cancer
-
Probst S, Bjartell A, Anand A, Skamene T, Ferrario C
- KMID: 2532369
- Nucl Med Mol Imaging.
- 2022 Aug;56(4):188-195.
- doi: 10.1007/s13139-022-00754-6
Background Radium-223, an alpha-emitting therapeutic radiopharmaceutical, prolongs overall survival (OS) in patients with symptomatic bone-predominant metastatic castration-resistant prostate cancer (mCRPC). PSMA PET/CT is a molecular imaging tool for whole-body imaging... -
- CITED
-
- Close
- SHARE
-
- Close
- Thyroglobulin‑Based Risk Factor Repositioning for Determining Radioactive Iodine Activity in Patients with Papillary Thyroid Carcinoma: a Multicenter Retrospective Cohort Study
-
Jeon S, Kwon S, Lee S, Bae S
- KMID: 2532367
- Nucl Med Mol Imaging.
- 2022 Aug;56(4):173-180.
- doi: 10.1007/s13139-022-00756-4
Purpose We aimed to investigate the impact of various factors including radioactive iodine (RAI) activity on the therapeutic response according to the range of serum thyroglobulin (Tg) in patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Pretreatment 18F‑FDG PET/CT‑Derived Parameters in Predicting Clinical Outcomes of Locally Advanced Upper Third Esophageal Squamous Cell Carcinoma After Definitive Chemoradiation Therapy
-
Ha L, Chau N, Bieu B, Son M
- KMID: 2532368
- Nucl Med Mol Imaging.
- 2022 Aug;56(4):181-187.
- doi: 10.1007/s13139-022-00751-9
Purpose The aim of this study was to investigate whether standard uptake values (SUVs) of pretreatment 18F-FDG PET/CT were the surrogate parameters for predicting the outcomes in locally advanced esophageal... -
- CITED
-
- Close
- SHARE
-
- Close
